This Study is to Compare the Efficacy of ZD6474 and ZD1839 in Subjects With NSCLC.

PHASE2CompletedINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

May 31, 2003

Study Completion Date

June 30, 2007

Conditions
Carcinoma, Non-Small-Cell Lung
Interventions
DRUG

ZD6474

DRUG

Placebo

DRUG

ZD1839

Trial Locations (48)

Unknown

Research Site, Pine Bluff

Research Site, Los Angeles

Research Site, Palm Springs

Research Site, San Diego

Research Site, Boca Raton

Research Site, Jacksonville

Research Site, Orange Park

Research Site, Coeur d'Alene

Research Site, Chicago

Research Site, Indianapolis

Research Site, Shreveport

Research Site, Saint Loius

Research Site, St Louis

Research Site, Brooklyn

Research Site, New York

Research Site, Greenville

Research Site, Bismarck

Research Site, Madison

Research Site, Buenos Aires

Research Site, Mendoza

Research Site, Brussels

Research Site, Brussels (Jette)

Research Site, Brussels (Woluwé-St-Lambert)

Research Site, Edegem

Research Site, Liège

Research Site, Wilrijk

Research Site, Hamburg

Research Site, Essen

Research Site, Mainz

Research Site, Berlin

Research Site, Ryhope

Research Site, Berlin

Research Site, Essen

Research Site, Hamburg

Research Site, Mainz

Research Site, Bloemfontein

Research Site, Cape Town

Research Site, Durban

Research Site, Johannesburg

Research Site, Lyttelton Manor

Research Site, Parktown

Research Site, Port Elizabeth

Research Site, Pretoria

Research Site, Northwood

Research Site, Cardiff

Research Site, Edinburgh

Research Site, Leeds

Research Site, Manchester

All Listed Sponsors
lead

Genzyme, a Sanofi Company

INDUSTRY

NCT00059722 - This Study is to Compare the Efficacy of ZD6474 and ZD1839 in Subjects With NSCLC. | Biotech Hunter | Biotech Hunter